| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN101223175B Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP |
| 03/26/2013 | US8404837 Quinoline derivatives as P13 kinase inhibitors |
| 03/26/2013 | US8404708 Dual NK1/NK3 receptor antagonists |
| 03/26/2013 | US8404704 Use of polymorphic forms of rifaximin for medical preparations |
| 03/26/2013 | US8404680 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1H-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors |
| 03/26/2013 | CA2581046C One-step preparation of 33-epichloro-33-desoxyascomycin |
| 03/26/2013 | CA2539659C Process for the synthesis of morphinane compounds and intermediates thereof |
| 03/21/2013 | WO2013039140A1 Fused heterocyclic derivative |
| 03/21/2013 | WO2013038407A1 Amorphous form of dolutegravir |
| 03/21/2013 | WO2013038308A1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS mPGES-1 INHIBITORS |
| 03/21/2013 | WO2013036994A1 Compounds for the treatment of hcv |
| 03/21/2013 | WO2011087995A3 Nitro - imidazo - oxazine derivatives and their use in the treatment of mycobacterial infections |
| 03/21/2013 | US20130072678 Spirooxazine radical derivatives and reversible isomerization reaction |
| 03/21/2013 | US20130072677 Novel hydroxamic acid derivative |
| 03/21/2013 | US20130072676 Use of polyols to obtain stable polymorphous forms of rifaximin |
| 03/21/2013 | US20130072502 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 03/21/2013 | US20130072501 2,5-substituted oxazolopyrimidine derivatives |
| 03/20/2013 | EP2570418A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound |
| 03/20/2013 | EP2570414A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/20/2013 | EP2569320A2 (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants |
| 03/20/2013 | EP2569310A1 Morpholine compounds as mineralocorticoid receptor antagonists |
| 03/20/2013 | CN102985413A Tricarbonyl technetium-99m or rhenium-188 label ring RGD derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseas |
| 03/20/2013 | CN102985405A Heterocyclic compound, and p27 kip1 degradation inhibitor |
| 03/20/2013 | CN102977118A Novel antibiotic of Gram-positive bacteria and its preparation method and use |
| 03/20/2013 | CN102977117A Method for synthesizing 6-bromo-2, 2-dimethyl-2H-pyridino [3, 2-B] [1, 4] oxazine-3(4H)-one |
| 03/20/2013 | CN102973947A Antibody-drug conjugates and methods |
| 03/20/2013 | CN101486714B Novel oxazine compound and use for preventing platelet aggregation |
| 03/19/2013 | US8399672 Compound having affinity for amyloid |
| 03/19/2013 | US8399659 Compounds and methods for inhibiting mitotic progression |
| 03/19/2013 | US8399476 Imidazo[1,2-a]pyridines and their use as pharmaceuticals |
| 03/19/2013 | CA2524027C Immunosuppressant compounds and compositions |
| 03/14/2013 | WO2013036053A2 Solid dispersion comprising tacrolimus and method for preparing the same |
| 03/14/2013 | US20130065901 2-aminopyridine analogs as glucokinase activators |
| 03/14/2013 | US20130065883 Triazolo [4, 5- B] Pyridin Derivatives |
| 03/14/2013 | US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors |
| 03/14/2013 | CA2847019A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases |
| 03/13/2013 | EP2566872A1 Compounds for the treatment of hepatitis c |
| 03/13/2013 | EP2566869A1 Pyridone and aza-pyridone compounds and methods of use |
| 03/13/2013 | CN102971902A Ionic liquids for batteries |
| 03/13/2013 | CN102971325A Compounds for the reduction of beta-amyloid production |
| 03/13/2013 | CN102971319A Bridged triarylamines and -phosphines as materials for electronic devices |
| 03/12/2013 | US8394792 Heterocyclic derivatives |
| 03/12/2013 | US8394786 Quinazoline derivatives |
| 03/12/2013 | CA2668210C Anilinopiperazine derivatives and methods of use thereof |
| 03/07/2013 | WO2013033245A1 Bicyclic methylene aziridines and reactions thereof |
| 03/07/2013 | WO2013032939A1 Bicyclic agonists of gpr131 and uses thereof |
| 03/07/2013 | WO2013032804A1 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
| 03/07/2013 | US20130059877 Treatment of solid tumors with rapamycin derivatives |
| 03/07/2013 | US20130059845 Bicyclic agonists of gpr131 and uses thereof |
| 03/07/2013 | US20130059837 Benzazepine compound |
| 03/07/2013 | CA2843514A1 (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists |
| 03/06/2013 | EP2563796A1 Aza-bicyclic amine n-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs |
| 03/06/2013 | EP2563765A1 Bicyclic compound derivatives and their use as acc inhibitors. |
| 03/06/2013 | CN102958935A Macrocyclic integrase inhibitors |
| 03/06/2013 | CN102958932A Modulators of 5-HT receptors and methods of use thereof |
| 03/06/2013 | CN102958918A Novel nicotinamide derivatives or salts thereof |
| 03/05/2013 | US8389515 2,4-pyrimidinediamine compounds and prodrugs and their uses |
| 03/05/2013 | US8389514 Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
| 02/28/2013 | WO2013028587A1 1,4-diazabicyclo[3.2.2]nonanes as neuronal nicotinic acetylcholine receptor ligands |
| 02/28/2013 | WO2013028382A1 Benzopiperazine derivatives as cetp inhibitors |
| 02/28/2013 | WO2013027845A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 02/28/2013 | WO2013027227A1 Novel polymorphic form i of rifaximin |
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053377 Inhibitors of beta-secretase |
| 02/28/2013 | US20130053365 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 02/28/2013 | US20130052205 Flt3 receptor antagonists for the treatment or the prevention of pain disorders |
| 02/28/2013 | CA2846122A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 02/28/2013 | CA2844764A1 1,4-diazabicyclo[3.2.2]nonanes as neuronal nicotinic acetylcholine receptor ligands |
| 02/27/2013 | EP2562157A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 02/27/2013 | EP2560973A1 Modulators of 5-ht receptors and methods of use thereof |
| 02/27/2013 | CN102947303A Bicyclic pyrimidinyl pyrazoles |
| 02/27/2013 | CN102947289A Arylethynyl derivatives |
| 02/27/2013 | CN102942581A Spirocyclo-quaternary ammonium salt for supercapacitor and preparation method of spirocyclo-quaternary ammonium salt |
| 02/27/2013 | CN102942574A Novel process for producing rifamycin S |
| 02/27/2013 | CN101223179B Biologically active compounds obtainable from sorangium cellulosum |
| 02/26/2013 | CA2608468C Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 02/21/2013 | US20130046093 Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same |
| 02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/21/2013 | US20130045972 Glucocorticoid receptor antagonists |
| 02/21/2013 | US20130045962 Peptide deformylase inhibitors |
| 02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 02/20/2013 | EP2559693A1 Polycyclic compound |
| 02/20/2013 | EP2559687A1 Mesoionic pesticides |
| 02/20/2013 | EP2558474A1 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 02/20/2013 | EP2558465A1 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |
| 02/20/2013 | EP2558457A1 Arylethynyl derivatives |
| 02/20/2013 | CN102939284A Agent for treating hcv infection |
| 02/20/2013 | CN102936857A Production method of photochromic fabric |
| 02/20/2013 | CN102936253A Preparation method of high-purity tacrolimus |
| 02/19/2013 | CA2557054C (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 02/19/2013 | CA2508657C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/14/2013 | WO2013022458A1 Methods of converting amorphous drug substance into crystalline form |
| 02/14/2013 | WO2013022238A2 Tricyclic glycosylated derivative compound, a production method therefor, and an immunosuppressant pharmaceutical composition comprising a tacrolimus glycosylation derivative |
| 02/14/2013 | WO2013022201A1 Process of preparing a stabilized and solubilized formulation of sirolimus derivatives |
| 02/14/2013 | WO2013021363A1 Quinazoline-2,4-dione derivatives |
| 02/14/2013 | WO2013021344A1 Imidazole derivatives as antiviral agents |
| 02/14/2013 | WO2013020164A1 Compounds for treating respiratory syncytial virus infections |
| 02/14/2013 | US20130040978 Spiro isoxazoline compounds as sstr5 antagonists |
| 02/14/2013 | US20130040943 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |